Researchers can generate thousands of promising molecular designs but lack capacity to synthesize them.
Build a service that accepts digital molecular designs and returns physical samples for testing.
Charge pharmaceutical and materials science startups needing to validate AI predictions quickly.
Start with common synthesis methods for small batches, then expand capabilities.
Major risk is regulatory hurdles around chemical handling and shipping.